Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Generic drug

Cytarabine price, strengths & recalls

Cytarabine has no weekly pharmacy acquisition cost. 5 manufacturers make it. It has 4 recalls on record, none ongoing. Its official label last changed on July 7, 2022.

Generic
No weekly pricePharmacy acquisition costs aren't published for this drug - usually because it's given in clinics or hospitals.

Cytarabine price by strength

What pharmacies pay for each strength and form this week, for the usual package. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
20 mg/mL injectionNot priced this week
20 mg/mL, 5 mL injectionNot priced this week
100 mg/mL, 20 mL injectionNot priced this week

Supply status: shortages & recalls

No shortage reportedChecked Nov 16, 2026
No ongoing recalls4 recalls on record, latest Aug 21, 2019

Recalls

A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.

What did you pay for cytarabine? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedJuly 7, 2022
Version3 of 2
EffectiveJul 6, 2022
Read the label

Cytarabine Injection(For Intravenous or Subcutaneous Use)

This drug has a boxed warning

WARNING

Only physicians experienced in cancer chemotherapy should use cytarabine.

For induction therapy patients should be treated in a facility with laboratory and supportive resources sufficient to monitor drug tolerance and protect and maintain a patient compromised by drug toxicity. The main toxic effect of cytarabine is bone marrow suppression with leukopenia, thrombocytopenia and anemia. Less serious toxicity includes nausea, vomiting, diarrhea and abdominal pain, oral ulceration, and hepatic dysfunction.

The physician must judge possible benefit to the patient against known toxic effects of this drug in considering the advisability of therapy with cytarabine. Before making this judgment or beginning treatment, the physician should be familiar with the following text.

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Generic makers
11 approved generic applications on the market

Cytarabine questions

Is cytarabine in shortage?

No shortage is reported for cytarabine right now. We check the national shortage list every day.

Has cytarabine been recalled?

4 recalls on record, none ongoing. Recalls name specific lots - check yours.

When did the cytarabine label last change?

The official label was last updated on July 7, 2022 (version 3). See what changed.

Talk about cytarabine

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.